NCT00785616

A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 55 (estimated)
• Sponsor: Montefiore Medical Center · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

This study will enroll completers of a prior 24 week MEMS cap study of Kaletra adherence, conducted in 2005 - 2006, and repeat the MEMS monitoring for an additional 24 weeks in 2008/2009 on the current antiretroviral anchor drug. The goals of the study are to correlate long-term adherence with virologic outcome, and to explore the stability of MEMS cap adherence measurements over time.

Conditions

• HIV Infection

Interventions

Type	Name	Description
OTHER	MEMS cap monitoring	Electronic monitoring of medication adherence using MEMS caps
OTHER	MEMS cap monitoring	Adherence to antiretroviral medications will be measured using electronic bottle caps (MEMS caps) that record the time signature of each bottle opening.
OTHER	MEMS cap monitoring	Adherence to antiretroviral medications will be measured using electronic bottle caps (MEMS caps) that record the time/date signature of each bottle opening.

Timeline

• Start date: 2008-09-01
• Primary completion: 2009-08-01
• Completion: 2009-10-01
• First posted: 2008-11-05
• Last updated: 2018-04-27

Locations

1 site across 1 country: United States